State-of-the-art management of locally advanced head and neck cancer.
about
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitorsNanotechnology in dentistry: prevention, diagnosis, and therapyAn indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivinSquamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelinesMicrobubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo.Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysisNano-bio-chip sensor platform for examination of oral exfoliative cytologySensitivity of salivary glands to radiation: from animal models to therapiesEpidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancerAnalysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impactSingle sample expression-anchored mechanisms predict survival in head and neck cancer.Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma.Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).Papillary thyroid microcarcinoma with synchronous asymptomatic advanced esophageal squamous cell carcinoma: A case report and review of the literature.Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality.Activity of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid against human head and neck carcinoma xenograftsA new bio-nanochip sensor aids oral cancer detectionSurvival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.Significance of lymph node metastasis in cancer dissemination of head and neck cancerHigh survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.A combined DNA-affinic molecule and N-mustard alkylating agent has an anti-cancer effect and induces autophagy in oral cancer cells.Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis.A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.A clinical audit of the nutritional status and need for nutrition support amongst head and neck cancer patients treated with radiotherapy.The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinomaDocetaxel in the treatment of squamous cell carcinoma of the head and neckAnalysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.Negative expression of N-acetylglucosaminyltransferase V in oral squamous cell carcinoma correlates with poor prognosis.Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas.Mononuclear phagocytes in head and neck squamous cell carcinoma.Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis.Emerging insights into head and neck cancer metastasis.Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.Incidence of hospitalization in patients with head and neck cancer treated with intensity-modulated radiation therapy.Chemoradiotherapy is superior to radiotherapy alone after surgery in advanced squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
P2860
Q26750719-38FF7117-638A-43A4-A759-FE102CB85350Q26778689-2B60E1C0-A7EF-4313-A119-27925B5C8C5CQ27310385-766B906B-BE3B-4B84-B9BB-864C329FF854Q27686904-9DEC8C86-CBC7-465E-B787-DAD0B7AF30D8Q30464657-2EC00B07-F0AD-45B2-8252-4EC82316DAD2Q33265638-476FF352-6E38-49C3-B540-A4F23AC2D15DQ33785690-B8E2028E-21D6-4EE4-BC9B-0AB5A4969068Q33901931-BB051797-B42C-4E46-8E18-85467001340CQ33990915-F5A6376F-C566-4404-8E09-6DE6817AC2E8Q34068822-569D52A8-9893-461C-A747-5604A7F1D668Q34145659-6A54ED4E-A6D4-4695-9595-3463820D75DBQ34289206-8E5A7151-E0BC-4380-889C-0EBCBB313EE9Q34511068-EDF6F5B3-FCC3-4D21-BFE5-C202EE7215D2Q34671206-E93F555C-6E96-4FAC-B518-61399E3A7CE8Q34993947-E07A61B4-8B13-4759-86FB-7B8FB31F1C64Q35076845-934E8511-814E-432A-9CD2-7BD4AF0038CCQ35082693-080CB29B-F71D-4309-83A0-E63A89850529Q35143570-1F0DB706-B4B8-4D96-9CAD-E8F430F986A0Q35551059-FC3ACDBA-9CF3-45FC-81DE-89C811489A7AQ35555487-10CD0FF5-1A74-4ED3-B8FC-C4CF37051CECQ35601686-B4EE2E38-7C09-4B3B-9E58-8A5251841863Q35652246-769B191C-6C0F-4315-933A-92E177950432Q35866026-775527F9-F323-4F21-A449-EA05829CC3A9Q35979835-841401D0-DA18-4C3F-BF1E-CB8CB083AF74Q36022400-E43DF9CB-9E9C-46BD-B25F-53DF5B36CA6CQ36147638-C883B00F-F2E0-4B05-8FEC-1BF63888A793Q36219713-A5081A7E-5272-49A3-BBD4-B3540004B7F8Q36452263-2186B864-5CBB-4E1B-B87F-A6BBF63948BCQ36568927-FE59CEF9-46B8-4701-984F-20B7888EC68CQ36887771-34BD034B-27B4-4A15-BA4B-44D0C5E217F5Q37052798-2A5B3585-D241-46FB-B49D-26AA75C317ACQ37308769-E8FDAFE8-FA9E-43B4-BEC7-C9D742522E02Q37392746-CF28D668-9196-4E77-94DD-4DD280D12169Q37565157-8D0579F5-8A05-4139-9BC1-2E6D3D9076F0Q37646333-6F8E7F91-4C80-4A81-A32F-6A6A6D912B63Q37930854-E8DC0A27-5626-4F5D-9BD3-FD48D9FF7EA4Q38070999-45DDA98B-0C60-4B77-8426-FFB38D1BA6B2Q38130138-0329A1EF-4E7B-49B1-9AC0-5F9FEE3BC5D8Q38225444-25E65B9E-8359-4817-9F7A-7E0EEE573923Q38263856-DA3576B1-DC53-4219-8E57-DC2FCA397004
P2860
State-of-the-art management of locally advanced head and neck cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
State-of-the-art management of locally advanced head and neck cancer.
@ast
State-of-the-art management of locally advanced head and neck cancer.
@en
type
label
State-of-the-art management of locally advanced head and neck cancer.
@ast
State-of-the-art management of locally advanced head and neck cancer.
@en
prefLabel
State-of-the-art management of locally advanced head and neck cancer.
@ast
State-of-the-art management of locally advanced head and neck cancer.
@en
P2860
P356
P1476
State-of-the-art management of locally advanced head and neck cancer.
@en
P2093
E E W Cohen
T Y Seiwert
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602510
P407
P577
2005-04-01T00:00:00Z
2005-04-25T00:00:00Z